Pediatrix Medical Group (NYSE:MD – Get Rating) posted its quarterly earnings results on Thursday. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.04, Briefing.com reports. Pediatrix Medical Group had a return on equity of 15.64% and a net margin of 4.73%. The business had revenue of $486.00 million for the quarter, compared to analyst estimates of $491.54 million. During the same period last year, the company earned $0.36 EPS. Pediatrix Medical Group’s revenue for the quarter was up 2.7% compared to the same quarter last year.
Pediatrix Medical Group Stock Up 1.7 %
Shares of MD traded up $0.32 on Friday, reaching $19.68. The stock had a trading volume of 1,443,245 shares, compared to its average volume of 605,852. The firm has a market capitalization of $1.72 billion, a price-to-earnings ratio of 18.39, a price-to-earnings-growth ratio of 1.39 and a beta of 1.84. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.63 and a current ratio of 1.63. The company has a 50-day simple moving average of $21.27 and a 200-day simple moving average of $22.13. Pediatrix Medical Group has a 12-month low of $17.17 and a 12-month high of $35.67.
Analysts Set New Price Targets
Several equities analysts recently issued reports on MD shares. TheStreet lowered Pediatrix Medical Group from a “b-” rating to a “c+” rating in a research report on Wednesday, April 13th. StockNews.com cut Pediatrix Medical Group from a “buy” rating to a “hold” rating in a report on Monday, May 2nd. Mizuho dropped their price objective on Pediatrix Medical Group from $28.00 to $23.00 in a report on Monday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on Pediatrix Medical Group from $24.00 to $16.00 in a report on Tuesday, May 10th. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group presently has a consensus rating of “Hold” and a consensus price target of $26.50.
Institutional Inflows and Outflows
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
- BJ’s Wholesale Club Stock Has More Room to Grow
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.